Loading clinical trials...
Loading clinical trials...
The goal of this study is to determine the effectiveness and safety of an annual intravenous treatment of zoledronic acid for the treatment of osteoporosis in men. All patients will receive calcium an...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis
NCT06449742 · Vertebral Fracture, Osteoporosis
NCT07474571 · Osteoarthitis, Osteoporosis
NCT06541548 · Osteoporosis Risk, Bone Loss
NCT07254429 · Menopausal Osteoporosis, Bone Markers
Catalina Pointe Clinical Research Inc.
Tucson, Arizona
Diablo Clinical Research
Walnut Creek, California
Colorado Center for Bone Research
Lakewood, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions